Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Optimizing ethambutol dosing among HIV/tuberculosis co-infected patients: a population pharmacokinetic modelling and simulation study.

Mehta K, Ravimohan S, Pasipanodya JG, Srivastava S, Modongo C, Zetola NM, Weissman D, Ivaturi V, Gumbo T, Bisson GP, Vinnard C.

J Antimicrob Chemother. 2019 Jul 4. pii: dkz265. doi: 10.1093/jac/dkz265. [Epub ahead of print]

PMID:
31273386
2.

Lung injury on antiretroviral therapy in adults with HIV/TB.

Ravimohan S, Auld SC, Maenetje P, Ratsela N, Mlotshwa M, Ncube I, Smith JP, Vangu MD, Sebe M, Kossenkov A, Weissman D, Wallis RS, Churchyard G, Kornfeld H, Bisson GP.

Clin Infect Dis. 2019 Jun 26. pii: ciz560. doi: 10.1093/cid/ciz560. [Epub ahead of print]

PMID:
31242296
3.

Common Variation in NLRP3 Is Associated With Early Death and Elevated Inflammasome Biomarkers Among Advanced HIV/TB Co-infected Patients in Botswana.

Ravimohan S, Nfanyana K, Tamuhla N, Tiemessen CT, Weissman D, Bisson GP.

Open Forum Infect Dis. 2018 Apr 11;5(5):ofy075. doi: 10.1093/ofid/ofy075. eCollection 2018 May.

4.

Tuberculosis and lung damage: from epidemiology to pathophysiology.

Ravimohan S, Kornfeld H, Weissman D, Bisson GP.

Eur Respir Rev. 2018 Feb 28;27(147). pii: 170077. doi: 10.1183/16000617.0077-2017. Print 2018 Mar 31. Review.

5.

Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation.

Vinnard C, Ravimohan S, Tamuhla N, Pasipanodya J, Srivastava S, Modongo C, Zetola NM, Weissman D, Gumbo T, Bisson GP.

PLoS One. 2017 Nov 2;12(11):e0187624. doi: 10.1371/journal.pone.0187624. eCollection 2017.

6.

Markers of gut dysfunction do not explain low rifampicin bioavailability in HIV-associated TB.

Vinnard C, Ravimohan S, Tamuhla N, Pasipanodya J, Srivastava S, Modongo C, Zetola NM, Weissman D, Gumbo T, Bisson GP.

J Antimicrob Chemother. 2017 Jul 1;72(7):2020-2027. doi: 10.1093/jac/dkx111.

7.

Elevated Pre-Antiretroviral Therapy CD39+CD8+ T Cell Frequency Is Associated With Early Mortality in Advanced Human Immunodeficiency Virus/Tuberculosis Co-infection.

Ravimohan S, Tamuhla N, Nfanyana K, Ni H, Steenhoff AP, Gross R, Weissman D, Bisson GP.

Clin Infect Dis. 2017 May 15;64(10):1453-1456. doi: 10.1093/cid/cix155. Erratum in: Clin Infect Dis. 2017 Oct 15;65(8):1431-1433.

8.

Isoniazid clearance is impaired among human immunodeficiency virus/tuberculosis patients with high levels of immune activation.

Vinnard C, Ravimohan S, Tamuhla N, Ivaturi V, Pasipanodya J, Srivastava S, Modongo C, Zetola NM, Weissman D, Gumbo T, Bisson GP.

Br J Clin Pharmacol. 2017 Apr;83(4):801-811. doi: 10.1111/bcp.13172. Epub 2016 Dec 9.

9.

Matrix Metalloproteinases in Tuberculosis-Immune Reconstitution Inflammatory Syndrome and Impaired Lung Function Among Advanced HIV/TB Co-infected Patients Initiating Antiretroviral Therapy.

Ravimohan S, Tamuhla N, Kung SJ, Nfanyana K, Steenhoff AP, Gross R, Weissman D, Bisson GP.

EBioMedicine. 2015 Nov 25;3:100-107. doi: 10.1016/j.ebiom.2015.11.040. eCollection 2016 Jan.

10.

Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+ T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.

Ravimohan S, Tamuhla N, Nfanyana K, Steenhoff AP, Letlhogile R, Frank I, MacGregor RR, Gross R, Weissman D, Bisson GP.

Clin Infect Dis. 2016 Mar 15;62(6):795-803. doi: 10.1093/cid/civ978. Epub 2015 Nov 26.

11.

Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study.

Ravimohan S, Tamuhla N, Steenhoff AP, Letlhogile R, Nfanyana K, Bellamy SL, MacGregor RR, Gross R, Weissman D, Bisson GP.

Lancet Infect Dis. 2015 Apr;15(4):429-38. doi: 10.1016/S1473-3099(15)70008-3. Epub 2015 Feb 9. Erratum in: Lancet Infect Dis. 2015 May;15(5):505.

12.

Outcomes in HIV-infected adults with tuberculosis at clinics with and without co-located HIV clinics in Botswana.

Schwartz AB, Tamuhla N, Steenhoff AP, Nkakana K, Letlhogile R, Chadborn TR, Kestler M, Zetola NM, Ravimohan S, Bisson GP.

Int J Tuberc Lung Dis. 2013 Oct;17(10):1298-303. doi: 10.5588/ijtld.12.0861.

13.

Early immunologic failure is associated with early mortality among advanced HIV-infected adults initiating antiretroviral therapy with active tuberculosis.

Ravimohan S, Tamuhla N, Steenhoff AP, Letlhogile R, Makutu DK, Nfanyana K, Rantleru T, Tierney A, Nkakana K, Schwartz AB, Gross R, Macgregor RR, Bellamy SL, Frank I, Weissman D, Bisson GP.

J Infect Dis. 2013 Dec 1;208(11):1784-93. doi: 10.1093/infdis/jit368. Epub 2013 Aug 1.

14.

Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis.

Bisson GP, Molefi M, Bellamy S, Thakur R, Steenhoff A, Tamuhla N, Rantleru T, Tsimako I, Gluckman S, Ravimohan S, Weissman D, Tebas P.

Clin Infect Dis. 2013 Apr;56(8):1165-73. doi: 10.1093/cid/cit019. Epub 2013 Jan 29. Erratum in: Clin Infect Dis. 2013 Oct;57(7):1067.

PMID:
23362285
15.

Early emergence and selection of a SIV-LTR C/EBP site variant in SIV-infected macaques that increases virus infectivity.

Ravimohan S, Gama L, Engle EL, Zink MC, Clements JE.

PLoS One. 2012;7(8):e42801. doi: 10.1371/journal.pone.0042801. Epub 2012 Aug 27. Erratum in: PLoS One. 2013;8(3). doi: 10.1371/annotation/050af66e-a935-46e6-96ec-5ac7e0fc4dfc.

16.
17.

Rare case of renal cell carcinoma with double inferior vena cava with venous thrombosis.

Kumar S, Panigrahy B, Ravimohan SM, Pandya S, Mandal AK, Singh SK.

Urology. 2008 Aug;72(2):461.e7-10. doi: 10.1016/j.urology.2007.12.020. Epub 2008 Mar 7.

PMID:
18314164
18.

Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse.

Collier LS, Carlson CM, Ravimohan S, Dupuy AJ, Largaespada DA.

Nature. 2005 Jul 14;436(7048):272-6.

19.

Postoperative pulmonary function in laparoscopic versus open cholecystectomy: prospective, comparative study.

Ravimohan SM, Kaman L, Jindal R, Singh R, Jindal SK.

Indian J Gastroenterol. 2005 Jan-Feb;24(1):6-8.

PMID:
15778517

Supplemental Content

Loading ...
Support Center